- Home
- FAT vs RGLS Comparison
FAT vs RGLS Comparison
Compare FAT & RGLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FAT
- RGLS
- Stock Information
- Founded
- FAT 2017
- RGLS 2007
- Country
- FAT United States
- RGLS United States
- Employees
- FAT N/A
- RGLS N/A
- Industry
- FAT Restaurants
- RGLS Biotechnology: Pharmaceutical Preparations
- Sector
- FAT Consumer Discretionary
- RGLS Health Care
- Exchange
- FAT Nasdaq
- RGLS Nasdaq
- Market Cap
- FAT 94.4M
- RGLS 102.1M
- IPO Year
- FAT 2017
- RGLS 2012
- Fundamental
- Price
- FAT $5.59
- RGLS $1.26
- Analyst Decision
- FAT
- RGLS Strong Buy
- Analyst Count
- FAT 0
- RGLS 6
- Target Price
- FAT N/A
- RGLS $10.33
- AVG Volume (30 Days)
- FAT 22.4K
- RGLS 315.1K
- Earning Date
- FAT 03-06-2025
- RGLS 03-20-2025
- Dividend Yield
- FAT 10.01%
- RGLS N/A
- EPS Growth
- FAT N/A
- RGLS N/A
- EPS
- FAT N/A
- RGLS N/A
- Revenue
- FAT $606,008,000.00
- RGLS N/A
- Revenue This Year
- FAT $27.15
- RGLS N/A
- Revenue Next Year
- FAT $10.38
- RGLS N/A
- P/E Ratio
- FAT N/A
- RGLS N/A
- Revenue Growth
- FAT 42.38
- RGLS N/A
- 52 Week Low
- FAT $4.51
- RGLS $1.15
- 52 Week High
- FAT $9.48
- RGLS $3.79
- Technical
- Relative Strength Index (RSI)
- FAT 63.48
- RGLS 35.32
- Support Level
- FAT $5.22
- RGLS $1.24
- Resistance Level
- FAT $5.39
- RGLS $1.40
- Average True Range (ATR)
- FAT 0.15
- RGLS 0.11
- MACD
- FAT 0.02
- RGLS -0.03
- Stochastic Oscillator
- FAT 87.50
- RGLS 19.15
About FAT FAT Brands Inc.
FAT Brands Inc is a multi-brand restaurant franchising company. It develops, markets, acquires and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts around the world. The company operates as a franchisor of restaurants, where the company generally does not own or operate the restaurant locations but rather generates revenue by charging franchisees an initial franchise fee as well as ongoing royalties. For some of the company's brands, it also directly owns and operates restaurant locations. Its brands include Round Table Pizza, Fatburger, Johnny Rockets, Twin Peaks, and Elevation Burger among others. Geographically, the majority of the revenue for the company is generated from the United States and the rest from other countries.
About RGLS Regulus Therapeutics Inc.
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.